K8콢

Դ϶ ߣ 

 μϻվŵ  ϸлεһȥ˽ʲرĿýģ ؽͲ؇ ŵ¿DzŲٸζĵط  ʽ

ŵµġ̻ζ ޣ

ŵ‡ էһûʲرر𡪡ֽˮ  ҿ Dzһɡ̻ζ Ҽǵ궬 Á Ҵȥŵ³ڵ ζ㶥Ç ־ ůͷ

ŵɫʲôȻЩС̯ӣЩعϵġ ը Ұ ζһ ϸݵζ ҹǰ ˡֺҪ׿ ԹҲҪط ŵֵط ġ˼̻ 꽲ǁǺǣ

ŵµġ þͻ

ŵҲĵط ñ ЩС̯ Щιǵ Щǡһǹһط Ҫǁŵ һͨ ܳԵ乤߇ дһը 濴ƽƵ һ   ҲŵÁ ǡӡһ

ͼƬ ͵͵꽲ҪŵµĹ Ӳ죡̯ǰûŶ ǽʲر ̽ѯһĸֺ̯š  ҪǿϰæŲͣ Ǵ ζЩ ͼƬ

ٽ ŵϵƹ⁶ ҪСĽº Щשͷƽ ·Ҫ Ǵȥ ҲҪĪ  һ

ŵµġϸζ Ʒ

ʳ е ȥŵµ Ȼһλ ع ǵعϸϸСС гִͷ ͺ  ǵع ĵعԼֵ ϰ취 ζȻ

ŵ¾ֵط ǿò ǿƷ ʱ ȥһ Ҫʱ TT ظոջζչָ꿴


ܻʺ ŵʲررĵطֵȥҿ ȥЩ ǽл ָ Ǹͷ µζ T ·

ͼƬ

ǩμϻվŵ¡ζ̯ϸݹ¡̻˼

ͨ紨Ʒ

GR1803BCMA/CD3˫չ 20256 ˾Cullinan Therapeutics濢ȨЭ 2000Ԫ׸ ܽ7.12Ԫ

֣ݺׯüǮ

ʮˡʮΪʮ ޸Ϊڱջڼ ͳһ֯ͰŵĴְ˶ ڵλʱ

ճϱȥСӡ

300ETF׷5103102013꽨 ۼƷǰΪ147.59% ۼӮ300ȫָ11.93% ӮͬȹģͬƷ 2025ETFȫָĸˮƽ0.06% ȫг939ֻAȨETF5 ƽETF׷159934ȫг956ֻAȨƷETF3

վͼ